Yarrow Bioscience, Inc. (YARW)
NASDAQ: YARW · Real-Time Price · USD
30.91
+2.86 (10.18%)
Jul 29, 2026, 4:00 PM EDT - Market closed
[Name] Market Cap
Yarrow Bioscience has a market cap or net worth of $87.95 million as of July 29, 2026. Its market cap has increased by 6,994.71% in one year.
Market Cap
87.95M
Enterprise Value
n/a
1-Year Change
6,994.71%
Ranking
n/a
Category
Stock Price
30.91
ChartMarket Cap Chart
Since July 30, 2021, Yarrow Bioscience's market cap has increased from $2.81M to $87.95M, an increase of 3,030.79%. That is a compound annual growth rate of 99.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2026 | 522.62K | 5.31% |
| Dec 31, 2025 | 496.27K | -82.64% |
| Dec 31, 2024 | 2.86M | 97.59% |
| Dec 29, 2023 | 1.45M | 797.65% |
| Dec 30, 2022 | 161.19K | -85.74% |
| Dec 31, 2021 | 1.13M | -59.77% |
| Jul 30, 2021 | 2.81M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Telomir Pharmaceuticals | 84.59M |
| Inovio Pharmaceuticals | 83.51M |
| Cognition Therapeutics | 80.76M |
| Kalaris Therapeutics | 78.99M |
| Alterity Therapeutics | 77.40M |
| NeurAxis | 76.60M |
| PolyPid | 76.50M |
| Champions Oncology | 76.28M |